WDR66, WD repeat domain 66, 144406

N. diseases: 26; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0021359
Disease: Infertility
Infertility
0.100 Biomarker phenotype HPO
CUI: C4022699
Disease: Sperm tail anomaly
Sperm tail anomaly
0.100 CausalMutation phenotype CLINVAR
CUI: C4022700
Disease: Sperm mid-piece anomaly
Sperm mid-piece anomaly
0.100 CausalMutation phenotype CLINVAR
CUI: C4539786
Disease: Absent sperm flagella
Absent sperm flagella
0.100 Biomarker phenotype HPO
CUI: C4539787
Disease: Short sperm flagella
Short sperm flagella
0.100 Biomarker phenotype HPO
CUI: C4539789
Disease: Coiled sperm flagella
Coiled sperm flagella
0.100 Biomarker phenotype HPO
Male infertility with teratozoospermia due to single gene mutation
0.100 CausalMutation disease CLINVAR
CUI: C4748395
Disease: SPERMATOGENIC FAILURE 33
SPERMATOGENIC FAILURE 33
0.100 CausalMutation disease CLINVAR
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.030 AlteredExpression phenotype BEFREE WDR66 expression is likely to play an important role in esophageal squamous cell carcinoma growth and invasion as a positive modulator of epithelial-mesenchymal transition. 23514407 2013
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.010 AlteredExpression group BEFREE WDR66 was identified to be required to maintain the EMT phenotype and the expression of cancer stem cell genes in the context of PTEN deficiency. 30569117 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.010 AlteredExpression group BEFREE WDR66 was identified to be required to maintain the EMT phenotype and the expression of cancer stem cell genes in the context of PTEN deficiency. 30569117 2019
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.010 AlteredExpression disease BEFREE A gene encoding WDR66, WD repeat-containing protein 66 was significantly highly expressed in esophageal squamous carcinoma specimens. 23514407 2013
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASDB A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. 24026423 2014
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASCAT A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. 24026423 2014
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASDB A genome-wide association study identifies three loci associated with mean platelet volume. 19110211 2009
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASCAT A genome-wide association study identifies three loci associated with mean platelet volume. 19110211 2009
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASDB A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. 19820697 2009
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASCAT A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. 19820697 2009
CUI: C0021364
Disease: Male infertility
Male infertility
0.020 GeneticVariation phenotype BEFREE A Homozygous Ancestral SVA-Insertion-Mediated Deletion in WDR66 Induces Multiple Morphological Abnormalities of the Sperm Flagellum and Male Infertility. 30122540 2018
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASDB A meta-analysis and genome-wide association study of platelet count and mean platelet volume in african americans. 22423221 2012
CUI: C0010606
Disease: Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma
0.010 Biomarker disease BEFREE Collectively, the results of the present study revealed a novel function of WDR66 in mediating the progression of PTEN‑deficient SACCs, thereby suggesting WDR66 inhibition to be a potential therapeutic approach towards successful management of SACC disease progression, particularly against tumors with decreased PTEN expression levels. 30569117 2019
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.030 Biomarker phenotype BEFREE Furthermore, knockdown of WDR66 decreased cellular proliferation, migration and invasion. 30569117 2019
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASCAT GWAS and PheWAS of red blood cell components in a Northern Nevadan cohort. 31194788 2019
CUI: C0029463
Disease: Osteosarcoma
Osteosarcoma
0.010 Biomarker disease BEFREE In conclusion, the present study proved that LINC00324 accelerated the proliferation and migration of osteosarcoma cells through regulating WDR66, providing a new prognostic target for osteosarcoma. 31225659 2020
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.010 Biomarker disease BEFREE In conclusion, the present study proved that LINC00324 accelerated the proliferation and migration of osteosarcoma cells through regulating WDR66, providing a new prognostic target for osteosarcoma. 31225659 2020